Daniel Wendorff

Daniel Wendorff is currently the Vice President and Head of Investor Relations at Qiagen, a position held since 2025. Previously, Daniel was the Senior Director of Investor Relations at Merck KGaA, and they have extensive experience in equity research, serving as Team Head for Life Science and Chemicals & Healthcare Equity Research at Commerzbank AG. Daniel's career began at WestLB, where they worked in Life Science Equity Research, and included significant roles at ODDO BHF and WestLB Panmure. Daniel holds a Diplom in Biology from Christian-Albrechts-Universität zu Kiel and certifications as a Certified International Investment Analyst and Certified EFFAS Financial Analyst from DVFA.